Part II  note 3 acquisitions 2009 acquisitions 2008 acquisitions Pro forma revenue, had the acquisitions of ISP and CoLiving occurred  on January 1, 2008, would have been $3,177.4 million for the year  ended December 31, 2008. This information is based on historical  results of operations, and, in our opinion, is not necessarily indicative  of the results that would have been achieved had we operated the  entities acquired since such dates. Pro forma net income and earnings  per share information related to these acquisitions are not presented  because the impact of these acquisitions on these measures in our  consolidated statements of income is not significant. As of the acquisition dates, we began to assess and formulate plans to  restructure the acquired entities. These activities were accounted for  in accordance with the then applicable accounting guidance related  to recognition of liabilities in connection with a purchase business  combination. The estimated costs have been recognized as liabilities in  the purchase price allocations above. Refer to Note 7 for a rollforward  of the restructuring activities related to the Alginates operations. The acquired intangible assets that are subject to amortization, primarily  customer relationships, have a weighted average useful life of 20 years.  The $31.1 million of goodwill, most of which is deductible for income  tax purposes, is included in our Specialty Chemicals segment. The following table presents the final purchase price allocation of our  Specialty Chemical segment acquisitions described above. During  the year ended December 31, 2009, we finalized the purchase price  allocation of these acquisitions, which resulted in an adjustment of  $8.4 million to goodwill (See Note 4). Pro forma revenue, net income and earnings per share information  related to these acquisitions are not presented because its impact on these  measures in our consolidated statements of income is not significant. The acquired intangible assets from these acquisitions that are subject to  amortization, primarily customer relationships, registration rights and  developed formulations, have useful lives ranging from 5 to 20 years. The CB acquisition included intangible assets of $12.1 million (primarily  customer relationships and trade names) and inventory of $1.7 million.  Approximately $1.0 million of the purchase price was accrued as  contingent consideration. The Benalaxyl acquisition totaled $20.0 million  and consisted of registration rights and trademarks. In September 2008, we acquired shares and assets comprising the food  ingredients business of the CoLiving Group. The acquisition enhanced  our position in supplying specialty hydrocolloid products and services  to the rapidly growing food ingredients market in China. The results of  operations of the CoLiving business have been included in the Specialty  Chemicals segment since the acquisition date of September 29, 2008. In August 2008, we acquired the hydrocolloids ingredients business  of International Specialty Products Inc. (“ISP”) based in Girvan,  Scotland. This acquisition strengthened our position in hydrocolloids  and enhanced service to global customers in food, pharmaceutical and  specialty industries. Under the agreement, we acquired ISP’s alginates  and food blends business (other than ISP’s Germinal blending business  based in Brazil), including ISP’s Girvan, Scotland, manufacturing facility  and employees. The results of operations of the ISP business have been  included in the Specialty Chemicals segment since the acquisition date  of August 18, 2008. In February 2009, we acquired the CB Professional Products line of insect  control products from Waterbury Companies, Inc. and in June 2009,  we acquired the proprietary fungicide Benalaxyl from Isagro S.p.A.  Both of these acquisitions have been integrated into our Agricultural  Products Group and fit our strategic goal of offering an expanded  product portfolio in focus markets and geographic segments. The CB  Professional Products line provides a comprehensive set of solutions to  pest management professionals primarily in the United States. Benalaxyl  is a highly effective systematic fungicide and is registered in more than  50 countries with the majority of sales expected in the European Union  and Latin America. The combined purchase price for both acquisitions  was approximately $34 million. The results of operations of the above  acquisitions have been included in the Agricultural Products segment  since their acquisition dates of February and June 2009, respectively. During the third quarter of 2008, we acquired the two businesses  described below for approximately $97 million. We paid $89.7 million  in cash for these two businesses which represents the purchase price  of approximately $97 million less cash acquired. The businesses were  integrated into our Specialty Chemicals segment’s BioPolymer Division. (in Millions) Current Assets (primarily inventory) $45.4 Property, Plant & Equipment 16.2 Intangible Assets (primarily customer relationships) 17.4 Goodwill 31.1 Deferred Tax Assets 12.2 Total Assets Acquired $122.3 Current Liabilities 22.2 Long-Term Liabilities (primarily deferred tax liability) 3.0 Net Assets $97.1 44 FMC Corporation    2010 Form 10K